Annual EBITDA
-$7.09 M
-$2.68 M-60.83%
December 31, 2023
Summary
- As of February 24, 2025, GCTK annual EBITDA is -$7.09 million, with the most recent change of -$2.68 million (-60.83%) on December 31, 2023.
- During the last 3 years, GCTK annual EBITDA has fallen by -$4.01 million (-129.85%).
- GCTK annual EBITDA is now -505.91% below its all-time high of -$1.17 million, reached on December 31, 2009.
Performance
GCTK EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$3.24 M
+$1.24 M+27.70%
September 30, 2024
Summary
- As of February 24, 2025, GCTK quarterly EBITDA is -$3.24 million, with the most recent change of +$1.24 million (+27.70%) on September 30, 2024.
- Over the past year, GCTK quarterly EBITDA has stayed the same.
- GCTK quarterly EBITDA is now -560.62% below its all-time high of -$490.60 thousand, reached on June 30, 2011.
Performance
GCTK Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$13.09 M
-$1.03 M-8.55%
September 30, 2024
Summary
- As of February 24, 2025, GCTK TTM EBITDA is -$13.09 million, with the most recent change of -$1.03 million (-8.55%) on September 30, 2024.
- Over the past year, GCTK TTM EBITDA has stayed the same.
- GCTK TTM EBITDA is now -2347.27% below its all-time high of -$534.80 thousand, reached on March 31, 2011.
Performance
GCTK TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
GCTK EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -60.8% | 0.0% | 0.0% |
| 3 y3 years | -129.8% | 0.0% | 0.0% |
| 5 y5 years | -6.8% | 0.0% | 0.0% |
GCTK EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -80.0% | at low | -250.8% | +27.7% | -232.3% | at low |
| 5 y | 5-year | -129.8% | at low | -446.2% | +27.7% | -365.4% | at low |
| alltime | all time | -505.9% | +30.7% | -560.6% | +56.9% | -2347.3% | at low |
GlucoTrack EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$3.24 M(-27.7%) | -$13.09 M(+8.6%) |
| Jun 2024 | - | -$4.48 M(+52.1%) | -$12.06 M(+37.8%) |
| Mar 2024 | - | -$2.95 M(+21.9%) | -$8.75 M(+23.5%) |
| Dec 2023 | -$7.09 M(+60.8%) | -$2.42 M(+9.4%) | -$7.08 M(+19.1%) |
| Sep 2023 | - | -$2.21 M(+87.9%) | -$5.95 M(+27.6%) |
| Jun 2023 | - | -$1.18 M(-8.1%) | -$4.66 M(+1.3%) |
| Mar 2023 | - | -$1.28 M(-0.2%) | -$4.61 M(+4.4%) |
| Dec 2022 | -$4.41 M(+11.9%) | -$1.28 M(+38.9%) | -$4.41 M(-3.4%) |
| Sep 2022 | - | -$924.00 K(-17.4%) | -$4.56 M(+3.8%) |
| Jun 2022 | - | -$1.12 M(+3.1%) | -$4.39 M(+6.2%) |
| Mar 2022 | - | -$1.08 M(-24.5%) | -$4.14 M(+5.1%) |
| Dec 2021 | -$3.94 M(+27.7%) | -$1.44 M(+89.9%) | -$3.94 M(+16.9%) |
| Sep 2021 | - | -$756.00 K(-12.4%) | -$3.37 M(-3.4%) |
| Jun 2021 | - | -$863.00 K(-2.4%) | -$3.49 M(+8.2%) |
| Mar 2021 | - | -$884.00 K(+2.1%) | -$3.23 M(+4.5%) |
| Dec 2020 | -$3.08 M(-10.7%) | -$866.00 K(-1.0%) | -$3.08 M(+9.7%) |
| Sep 2020 | - | -$875.00 K(+45.8%) | -$2.81 M(-3.2%) |
| Jun 2020 | - | -$600.00 K(-19.4%) | -$2.91 M(-8.9%) |
| Mar 2020 | - | -$744.00 K(+25.4%) | -$3.19 M(-7.5%) |
| Dec 2019 | -$3.46 M(-48.0%) | -$593.40 K(-38.7%) | -$3.45 M(-17.5%) |
| Sep 2019 | - | -$968.50 K(+9.8%) | -$4.18 M(-12.5%) |
| Jun 2019 | - | -$882.40 K(-12.1%) | -$4.78 M(-18.4%) |
| Mar 2019 | - | -$1.00 M(-24.3%) | -$5.86 M(-12.3%) |
| Dec 2018 | -$6.64 M(-35.2%) | -$1.33 M(-15.4%) | -$6.69 M(-16.4%) |
| Sep 2018 | - | -$1.57 M(-20.2%) | -$7.99 M(-11.1%) |
| Jun 2018 | - | -$1.96 M(+7.4%) | -$8.99 M(-6.0%) |
| Mar 2018 | - | -$1.83 M(-30.6%) | -$9.56 M(-7.3%) |
| Dec 2017 | -$10.24 M | -$2.63 M(+2.8%) | -$10.31 M(+17.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | -$2.56 M(+1.1%) | -$8.80 M(+14.7%) |
| Jun 2017 | - | -$2.53 M(-2.0%) | -$7.67 M(+14.4%) |
| Mar 2017 | - | -$2.58 M(+130.9%) | -$6.70 M(+25.7%) |
| Dec 2016 | -$5.33 M(-7.8%) | -$1.12 M(-22.1%) | -$5.33 M(-7.1%) |
| Sep 2016 | - | -$1.44 M(-8.3%) | -$5.74 M(+6.5%) |
| Jun 2016 | - | -$1.57 M(+29.2%) | -$5.39 M(-1.5%) |
| Mar 2016 | - | -$1.21 M(-20.4%) | -$5.47 M(-5.4%) |
| Dec 2015 | -$5.78 M(+61.8%) | -$1.52 M(+40.6%) | -$5.78 M(-50.2%) |
| Sep 2015 | - | -$1.08 M(-34.4%) | -$11.60 M(+2.8%) |
| Jun 2015 | - | -$1.65 M(+8.4%) | -$11.29 M(+7.4%) |
| Mar 2015 | - | -$1.52 M(-79.3%) | -$10.52 M(+8.2%) |
| Dec 2014 | -$3.57 M(-63.3%) | -$7.35 M(+850.8%) | -$9.72 M(-1.8%) |
| Sep 2014 | - | -$772.60 K(-11.6%) | -$9.89 M(+0.5%) |
| Jun 2014 | - | -$873.80 K(+20.3%) | -$9.84 M(+0.5%) |
| Mar 2014 | - | -$726.50 K(-90.3%) | -$9.79 M(+0.5%) |
| Dec 2013 | -$9.75 M(+254.6%) | -$7.52 M(+946.6%) | -$9.75 M(+244.3%) |
| Sep 2013 | - | -$718.70 K(-12.8%) | -$2.83 M(+1.2%) |
| Jun 2013 | - | -$824.10 K(+21.0%) | -$2.80 M(+2.8%) |
| Mar 2013 | - | -$680.80 K(+12.2%) | -$2.72 M(+1.5%) |
| Dec 2012 | -$2.75 M(+17.9%) | -$606.80 K(-11.5%) | -$2.68 M(-0.2%) |
| Sep 2012 | - | -$686.00 K(-8.3%) | -$2.69 M(-0.3%) |
| Jun 2012 | - | -$747.80 K(+16.6%) | -$2.69 M(+10.6%) |
| Mar 2012 | - | -$641.50 K(+4.9%) | -$2.44 M(+4.6%) |
| Dec 2011 | -$2.33 M(+69.9%) | -$611.30 K(-11.9%) | -$2.33 M(+35.6%) |
| Sep 2011 | - | -$694.00 K(+41.5%) | -$1.72 M(+67.7%) |
| Jun 2011 | - | -$490.60 K(-8.3%) | -$1.03 M(+91.7%) |
| Mar 2011 | - | -$534.80 K | -$534.80 K |
| Dec 2010 | -$1.37 M(+17.2%) | - | - |
| Dec 2009 | -$1.17 M | - | - |
FAQ
- What is GlucoTrack annual EBITDA?
- What is the all time high annual EBITDA for GlucoTrack?
- What is GlucoTrack annual EBITDA year-on-year change?
- What is GlucoTrack quarterly EBITDA?
- What is the all time high quarterly EBITDA for GlucoTrack?
- What is GlucoTrack quarterly EBITDA year-on-year change?
- What is GlucoTrack TTM EBITDA?
- What is the all time high TTM EBITDA for GlucoTrack?
- What is GlucoTrack TTM EBITDA year-on-year change?
What is GlucoTrack annual EBITDA?
The current annual EBITDA of GCTK is -$7.09 M
What is the all time high annual EBITDA for GlucoTrack?
GlucoTrack all-time high annual EBITDA is -$1.17 M
What is GlucoTrack annual EBITDA year-on-year change?
Over the past year, GCTK annual EBITDA has changed by -$2.68 M (-60.83%)
What is GlucoTrack quarterly EBITDA?
The current quarterly EBITDA of GCTK is -$3.24 M
What is the all time high quarterly EBITDA for GlucoTrack?
GlucoTrack all-time high quarterly EBITDA is -$490.60 K
What is GlucoTrack quarterly EBITDA year-on-year change?
Over the past year, GCTK quarterly EBITDA has changed by $0.00 (0.00%)
What is GlucoTrack TTM EBITDA?
The current TTM EBITDA of GCTK is -$13.09 M
What is the all time high TTM EBITDA for GlucoTrack?
GlucoTrack all-time high TTM EBITDA is -$534.80 K
What is GlucoTrack TTM EBITDA year-on-year change?
Over the past year, GCTK TTM EBITDA has changed by $0.00 (0.00%)